- US12600779utility2026Lag-3-binding Molecules and Methods of Use Thereof0 cites
- US12534531utility2026Pd-1-binding Molecules and Methods of Use Thereof0 cites
- US12448448utility2025Anti-pd-1 Antibodies and Uses Thereof0 cites
- US12435155utility2025CD137 Binding Molecules and Uses Thereof0 cites
- US12364756utility2025Pharmaceutical Compositions of a PD-1 Antibody and Use of the Same0 cites
- US12024569utility2024Her2/neu-specific Antibodies and Methods of Using Same0 cites
- US11942149utility2024Bispecific Binding Molecules That Are Capable of Binding CD137 and Tumor Antigens, and Uses Thereof0 cites
- US11884744utility2024Compound Targeting IL-23A and B-cell Activating Factor (BAFF) and Uses Thereof0 cites
- US11858991utility2024Lag-3-binding Molecules and Methods of Use Thereof0 cites
- US11840571utility2023Methods of Using Bispecific Molecules Having Immunoreactivity with PD-1 and CTLA-40 cites
- US11820818utility2023Multi-chain Polypeptide-containing Tri-specific Binding Molecules0 cites
- US11795226utility2023Bispecific Cd16-binding Molecules and Their Use in the Treatment of Disease0 cites
- US11697684utility2023Tri-specific Binding Molecules That Specifically Bind to Multiple Cancer Antigens0 cites
- US11680096utility2023Compound Targeting IL-23A and Tnf-alpha and Uses Thereof0 cites
- US11639386utility2023Bi-specific Monovalent Diabodies That Are Capable of Binding CD19 and CD3, and Uses Thereof0 cites
- US11623959utility2023Pd-1-binding Molecules and Methods of Use Thereof0 cites
- US11591400utility2023B7-H3 Directed Antibody Drug Conjugates0 cites